New Adjuvant to Surgery Improved Pancreatic Cancer Survival

SAN FRANCISCO (IMNG) - Japanese patients who underwent surgery for pancreatic cancer were 44% less likely to die within 2 years if they were treated postoperatively with the chemotherapy drug S-1, compared...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news